
Cleopatra AI is a mobile application designed specifically for nose editing and rhinoplasty simulations. It allows users to reshape, retouch, and visualize potential nose job results through realistic previews. The app is focused on editing only the nose area, providing tools for fixing nose humps, refining the nose tip, adjusting width, and correcting asymmetry, all while maintaining facial harmony. Users can upload a clear photo, apply various editing filters, and compare before-and-after images to aid in decision-making before consulting with a plastic surgeon.
Notable features of Cleopatr…
The app has real paying users and a subscription footprint (MRR $463), which is the strongest signal here — it’s not a prototype. However, the business is small in absolute scale ($550) and showed a month-over-month contraction (-18%), so momentum is a clear short-term risk. The reported margin (90%) is unusually high, implying low operating costs or capital-light delivery, which helps make the current revenue more defensible while growth is addressed.
For a founder, the immediate play is regaining positive growth: prioritize top-of-funnel traffic and conversion, or raising ARPU via premium features or B2B partnerships with clinics. For someone evaluating acquisition or backing, this is a compact, margin-efficient asset with paying customers but limited scale — the sale listing could be an opportunity, but confirm retention, CAC, and why the founder is exiting before pricing it as a growth asset.
A judgment from project data — not a user review.